Lenalidomide reexposure After Short Interruption In Del(5q) MDS Patients at Relapse of Transfusion Dependence

被引:0
|
作者
Radkowski, Robert Marek [1 ]
Haase, Sabine [1 ]
Schlegelberger, Brigitte [2 ]
Goehring, Gudrun [2 ]
Banisch, Stefanie [1 ]
Heinsch, Michael [1 ]
Aul, Carlo [1 ]
Giagounidis, Aristoteles [1 ]
机构
[1] St Johannes Hosp, Med Klin 2, Duisburg, Germany
[2] Hannover Med Sch, Inst Cell & Mol Pathol, D-3000 Hannover, Germany
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1204 / 1204
页数:1
相关论文
共 50 条
  • [21] Prognosis of patients with del(5q) MDS and complex karyotype and the possible role of lenalidomide in this patient subgroup
    Giagounidis, AAN
    Germing, U
    Strupp, C
    Hildebrandt, B
    Heinsch, M
    Aul, C
    ANNALS OF HEMATOLOGY, 2005, 84 (09) : 569 - 571
  • [22] Prognosis of patients with del(5q) MDS and complex karyotype and the possible role of lenalidomide in this patient subgroup
    A. A. N. Giagounidis
    U. Germing
    C. Strupp
    B. Hildebrandt
    M. Heinsch
    C. Aul
    Annals of Hematology, 2005, 84 : 569 - 571
  • [23] Clonal activation of Akt in low-risk MDS patients with del(5q) treated with lenalidomide
    Follo, M. Y.
    Mongiorgi, S.
    Clissa, C.
    Stoyanova, M.
    Paolini, S.
    Quaranta, M.
    Martinelli, G.
    Manzoli, L.
    Cocco, C.
    Finelli, C.
    LEUKEMIA RESEARCH, 2013, 37 : S28 - S28
  • [24] Clonal Effect Of Lenalidomide On Akt Activation In Low-Risk MDS Patients With Del(5q)
    Follo, Matilde Y.
    Finelli, Carlo
    Clissa, Cristina
    Mongiorgi, Sara
    Baldazzi, Carmen
    Stanzani, Marta
    Baccarani, Michele
    Cocco, Lucia
    BLOOD, 2013, 122 (21)
  • [25] Survival of Patients with Del(5q) Syndrome in the Lenalidomide Era
    Reagan, John L.
    Ollila, Thomas
    Dubielecka, Patrycja M.
    Olszewski, Adam J.
    BLOOD, 2016, 128 (22)
  • [26] Treating non-del 5q patients with lenalidomide
    Schiffer, C. A.
    LEUKEMIA RESEARCH, 2007, 31 : S9 - S10
  • [27] Lenalidomide induces ubiquitination and degradation of CK1a in del(5q) MDS
    Kroenke, Jan
    Fink, Emma C.
    Hollenbach, Paul W.
    MacBeth, Kyle J.
    Hurst, Slater N.
    Udeshi, Namrata D.
    Chamberlain, Philip P.
    Mani, D. R.
    Man, Hon Wah
    Gandhi, Anita K.
    Svinkina, Tanya
    Schneider, Rebekka K.
    McConkey, Marie
    Jaeras, Marcus
    Griffiths, Elizabeth
    Wetzler, Meir
    Bullinger, Lars
    Cathers, Brian E.
    Carr, Steven A.
    Chopra, Rajesh
    Ebert, Benjamin L.
    NATURE, 2015, 523 (7559) : 183 - U102
  • [28] Lenalidomide induces ubiquitination and degradation of CK1α in del(5q) MDS
    Jan Krönke
    Emma C. Fink
    Paul W. Hollenbach
    Kyle J. MacBeth
    Slater N. Hurst
    Namrata D. Udeshi
    Philip P. Chamberlain
    D. R. Mani
    Hon Wah Man
    Anita K. Gandhi
    Tanya Svinkina
    Rebekka K. Schneider
    Marie McConkey
    Marcus Järås
    Elizabeth Griffiths
    Meir Wetzler
    Lars Bullinger
    Brian E. Cathers
    Steven A. Carr
    Rajesh Chopra
    Benjamin L. Ebert
    Nature, 2015, 523 : 183 - 188
  • [29] MYELODYSPLASTIC SYNDROME WITH DEL(5Q) AND LENALIDOMIDE
    Gritsaev, S. V.
    Martinkevitch, I. S.
    Petrova, E. V.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2013, 58 (02): : 3 - 10
  • [30] Lenalidomide in AML: Del(5q) or who?
    Steensma, David P.
    Stone, Richard M.
    BLOOD, 2011, 118 (03) : 481 - 482